Bias, Corruption & Accountability

The US FDA on Wednesday approved a new type of drug for insomnia, called Belsroma. Last year, a lengthy investigative report in The New...

Researchers investigate the first-person experiences of people who disagreed with their psychiatric diagnosis of psychosis.

Organizations, advocates, scholars, and practitioners had a chance to give feedback regarding FDA processes.

Pharmaceutical industry executives who mislead the public could soon face fines of up to $5 million or two years in jail in Canada. According...

From Discover Magazine: Headlines in various news sources reporting on a new study claim that women's brains have been found to be more active than...

Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that was ghostwritten and then used by the manufacturers to support claims of the drug’s efficacy and safety in the treatment of child and adolescent depression. To get the background on this story, we connected with Dr. Leemon McHenry, an investigator in this study and a lecturer in philosophy at California State University, Northridge.

In this piece for the BMJ, Jeanne Lenzer profiles Vikas Saini, a cardiologist who is working to fight against excessive medical treatment. His work with...

Citing a 43 percent jump since 2003, researchers estimate that 5.8 million school-aged children and teens in the US now have an ADHD diagnosis, a staggering 12 percent of this population. The new NIH-funded analysis also found that the percentage of girls diagnosed with ADHD was up 55% and that the percentage of Hispanic children diagnosed shot up 83% over the same timeframe.

On Tuesday, the U.S. Food and Drug Administration (FDA) approved Flibanserin (Addyi) to treat low sexual desire in women despite concerns about the drug's limited efficacy and doubts over its clinical relevance. That the drug is being called the "pink Viagra" can be misleading as Viagra treats erectile dysfunction by improving blood flow while Flibanserin targets the brain, and must be taken daily.

In an effort to reduce coercion, researchers isolate associated factors including age, relationship status, location, and diagnosis.

From The New York Times: Many medical centers, professional associations, and states have developed patients' bills of rights. It is time to develop a Financial Bill of...

The International Business Times covers a new study showing “trials for new antidepressant medications may not be applicable to the population at large.” “The finding, published in the Mayo Clinic Proceedings, shows recent trials are less generalizable than the prior studies, as researchers excluded most depressed patients from drug company-sponsored treatment studies.”

If academic psychiatry is evidence-based, why did it take two decades to recognize SSRI withdrawal as widespread and chronic among patients?

Does maternal SSRI exposure increase the chances that a child will develop characteristics associated with Autism Spectrum Disorder (ASD)?

An internal government investigation found that authorities did not investigate 50% of deaths that occurred inside mental health services in Ireland, reports the Irish...

The Scientific American reports on an in-depth reanalysis revealing widespread underreporting of negative side effects, including suicide attempts and aggressive behavior. Article →

Researchers examine how rapid discontinuation can mimic the relapse of mental health symptoms and confound psychiatric drug studies.

In a new article for Scientific American, Diana Kwon reports on how the true risks for suicide and aggression in children and teens taking...

-Mind the Brain's James Coyne talks about why so many news stories about health and psychology studies are so bad.

Films for Action is now hosting a video by MIA contributor Bruce Levine. In his presentation, taped at his Oct 9, 2015 National Empowerment Center talk,...